AMICUS THERAPEUTICS INC. - COMMON STOCK

Amicus Therapeutics to Announce Third Quarter 2024 Financial Results on November 6, 2024

28 10 2024 04:00:00 提供 Nasdaq GlobeNewswire

Amicus Therapeutics Announces Settlement of Galafold® (migalastat) Patent Litigation with Teva

17 10 2024 04:00:00 提供 Nasdaq GlobeNewswire

Amicus Therapeutics Announces Participation at the World Muscle Society Annual Congress 2024

04 10 2024 04:00:00 提供 Nasdaq GlobeNewswire

UPDATE -- Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2024

03 9 2024 04:46:15 提供 Nasdaq GlobeNewswire

Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2024

03 9 2024 04:05:20 提供 Nasdaq GlobeNewswire

Amicus Therapeutics Announces Participation at the SSIEM 2024 Annual Symposium

03 9 2024 04:00:00 提供 Nasdaq GlobeNewswire

Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2024

30 8 2024 04:00:00 提供 Nasdaq GlobeNewswire

Amicus Therapeutics Announces Second Quarter 2024 Financial Results and Corporate Updates

08 8 2024 04:00:21 提供 Nasdaq GlobeNewswire

Amicus Therapeutics to Announce Second Quarter 2024 Financial Results on August 8, 2024

30 7 2024 04:00:00 提供 Nasdaq GlobeNewswire

Amicus Therapeutics to Present at the Goldman Sachs 45th Annual Global Healthcare Conference

05 6 2024 04:00:00 提供 Nasdaq GlobeNewswire

Amicus Therapeutics Receives Prix Galien U.K. Award for Pombiliti® (cipaglucosidase alfa) + Opfolda® (miglustat) as Best Pharmaceutical Product

04 6 2024 04:00:00 提供 Nasdaq GlobeNewswire

Amicus Therapeutics Announces First Quarter 2024 Financial Results and Corporate Updates

09 5 2024 04:00:01 提供 Nasdaq GlobeNewswire

Amicus Therapeutics to Present at the Bank of America 2024 Health Care Conference

08 5 2024 04:00:01 提供 Nasdaq GlobeNewswire

Amicus Therapeutics to Announce First Quarter 2024 Financial Results on May 9, 2024

01 5 2024 04:00:00 提供 Nasdaq GlobeNewswire

Amicus Therapeutics Issues 2024 Environmental, Social, and Governance (ESG) Report

20 3 2024 04:00:00 提供 Nasdaq GlobeNewswire

Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2024

01 3 2024 04:00:00 提供 Nasdaq GlobeNewswire

Amicus Therapeutics Announces Full-Year 2023 Financial Results and Corporate Updates

28 2 2024 04:00:00 提供 Nasdaq GlobeNewswire

Amicus Therapeutics to Announce Full Year 2023 Financial Results on February 28, 2024

15 2 2024 04:00:00 提供 Nasdaq GlobeNewswire

Amicus Therapeutics Receives the 2024 New Treatment Award for Pombiliti™ (cipaglucosidase alfa-atga) + Opfolda™ (miglustat) at the 20th Annual WORLDSymposium™

08 2 2024 04:00:00 提供 Nasdaq GlobeNewswire

Amicus Therapeutics Announces Presentations and Posters at the 20th Annual WORLDSymposium™ 2024

01 2 2024 04:00:00 提供 Nasdaq GlobeNewswire